Medical News

RSS

Sweep Technology, a new way for adjusting hearing aids

Starkey Laboratories, Inc., one of the world’s leading hearing technology companies, is excited to introduce Sweep™ Technology – providing a completely new way to adjust hearing aids.

29 Oct 2009

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a “significant strategy” in the future design of anti-aging pharmaceuticals.

29 Oct 2009

Centre for Addiction and Mental Health to say goodbye to its landmark Administration Building

The Centre for Addiction and Mental Health (CAMH) will say goodbye to its landmark Administration Building at 1001 Queen St. West in a ceremony on October 29, 2009 at 4 p.m. Demolition of the building will begin in January 2010 to make way for the next major phase of CAMH's ambitious redevelopment project, which is transforming care for Ontarians living with addiction and mental health issues.

29 Oct 2009

World Journal of Gastroenterology reports a case of metallic foreign body in lower mid-abdomen

Foreign body ingestion is a frequent gastrointestinal emergency. However, long spoon swallowing is a rare event. Most swallowed spoons have been found in the stomach. Previously, there has been no reported case of a long spoon reaching the jejunum.

29 Oct 2009

PSI to highlight the plight of world's migrant workers at GFMD

Public Services International, a global federation of public sector trade unions, will highlight the plight of the world’s migrant workers 2-5 November 2009 at the Civil Society Days of the Third Global Forum on Migration and Development (GFMD). PSI will call for wider access to quality public services, decent work, and economic policies that are fair to both workers and development efforts in their countries.

29 Oct 2009

PFNC presents Wake Forest psychiatrist the Eugene A. Hargrove, M.D., Award

Vaughn McCall, M.D., M.S., chair of Psychiatry and Behavioral Medicine at Wake Forest University Baptist Medical Center, has been presented the Eugene A. Hargrove, M.D., Award by the Psychiatric Foundation of North Carolina (PFNC).

29 Oct 2009

Perioperative oral dietary supplements before elective surgery offers no functional benefit

Blood glucose levels in a lot of patients fed normal liquid food (NLF) and a high calorie diet (HCD) were high. There was no significant difference in the blood prealbumin levels. There was a significant increase in the blood cortisol levels in some patients. The stress of surgery may be tolerated by children by feeding up to 2 h before elective surgery.

29 Oct 2009

Effects of head injuries on players in the NFL: House Judiciary Committee's call to experts

The House Judiciary Committee today called upon national experts and stakeholders in the fields of science and sport to better understand the effects of head injuries on players in the National Football League (NFL). Nationally recognized sports physician and neurosurgeon, Julian E. Bailes, M.D. was called to provide expert testimony based on decades of research detailing how repetitive head trauma on the field leads to long-term neurological damage among athletes.

29 Oct 2009

Fresenius Kabi to license its proprietary HESylation Technology to Octapharma

Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation® Technology to develop a HESylated recombinant protein.

29 Oct 2009

Conceptus reports clinical success of its Essure non-incisional permanent birth control procedure

Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the clinical success of the Essure® procedure will be highlighted at the 18th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE) in Florence, Italy from October 28-31, 2009.

29 Oct 2009

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

The following are highlights of new cancer research being presented at the American Society for Radiation Oncology's (ASTRO) 51st Annual Meeting on November 1-5, 2009, in Chicago.

29 Oct 2009

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Despite a recent study finding that an increasing number of women who had cancer in one breast are opting to have the other breast removed, the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology(TM) for Breast Cancer discourages prophylactic mastectomy in women except for those considered high risk.

29 Oct 2009

Cempra Pharmaceuticals to present CEM-102 data at the Infectious Diseases Society of America meeting

Cempra Pharmaceuticals today announced data presentations of its lead antibiotic candidate, CEM-102 (fusidic acid), at the Infectious Diseases Society of America, 47th Annual Meeting, Oct. 29 to Nov. 1, 2009, in Philadelphia.

29 Oct 2009

Long-term effects of statin therapy could lead to transient or permanent cognitive impairment

Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.

29 Oct 2009

Positive top-line results from Phase IIb clinical trial of cariprazine announced

Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.

29 Oct 2009

Intrauterine contraception is most popular amongst European women

A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynaecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old.

29 Oct 2009

CNS Protein Therapeutics changes its corporate name to Amarantus Therapeutics

CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. (“Amarantus”) and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.

29 Oct 2009

Cordis recalls its CROSSOVER Sheath Introducer

Cordis Corporation announced today a nationwide voluntary recall of all lots of the CROSSOVER™ Sheath Introducer due to complaints about stretching or fracture of the sheath during use.

29 Oct 2009

BioMed Realty Trust signs a ten-year lease with Broad Institute in Cambridge

BioMed Realty Trust, Inc. today announced the signing of a new lease at its 301 Binney Street laboratory research facility in Cambridge, Massachusetts. The world-renowned Broad Institute of MIT and Harvard agreed to a ten-year lease for approximately 80,000 square feet in the heart of Cambridge's biotechnology super-cluster.

29 Oct 2009

National study to prevent strokes in children and adolescents with sickle cell anemia

St. Jude Children's Research Hospital investigators were recently awarded a $23 million federal grant to launch a national study of the drug hydroxyurea to prevent first strokes in children and adolescents with sickle cell anemia (SCA).

29 Oct 2009

Medical News

Sweep Technology, a new way for adjusting hearing aids

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

Centre for Addiction and Mental Health to say goodbye to its landmark Administration Building

World Journal of Gastroenterology reports a case of metallic foreign body in lower mid-abdomen

PSI to highlight the plight of world's migrant workers at GFMD

PFNC presents Wake Forest psychiatrist the Eugene A. Hargrove, M.D., Award

Perioperative oral dietary supplements before elective surgery offers no functional benefit

Effects of head injuries on players in the NFL: House Judiciary Committee's call to experts

Fresenius Kabi to license its proprietary HESylation Technology to Octapharma

Conceptus reports clinical success of its Essure non-incisional permanent birth control procedure

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Cempra Pharmaceuticals to present CEM-102 data at the Infectious Diseases Society of America meeting

Long-term effects of statin therapy could lead to transient or permanent cognitive impairment

Positive top-line results from Phase IIb clinical trial of cariprazine announced

Intrauterine contraception is most popular amongst European women

CNS Protein Therapeutics changes its corporate name to Amarantus Therapeutics

Cordis recalls its CROSSOVER Sheath Introducer

BioMed Realty Trust signs a ten-year lease with Broad Institute in Cambridge

National study to prevent strokes in children and adolescents with sickle cell anemia

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News